Document is current
Any future updates will be listed below
-
Authors
Lechat, Bastien https://orcid.org/0000-0003-0760-0714
Nguyen, Duc Phuc
Sansom, Kelly
Pinilla, Lucia https://orcid.org/0000-0003-2825-4056
Scott, Hannah https://orcid.org/0000-0002-0707-8068
Reynolds, Amy C.
Vakulin, Andrew
Manners, Jack
Adams, Robert J.
Pepin, Jean-Louis https://orcid.org/0000-0003-3832-2358
Escourrou, Pierre https://orcid.org/0000-0003-0068-0563
Catcheside, Peter https://orcid.org/0000-0002-9372-6788
Eckert, Danny J. https://orcid.org/0000-0003-3503-2363
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (2025886, 1196261)
- License Information
-
More Information
Article History
Received: 8 January 2025
Accepted: 7 July 2025
First Online: 29 July 2025
Competing interest
: The authors declare the following competing interests: PE serves as a consultant for Withings. Outside the submitted work, BL has had research grants from Withings, the NHMRC and the Medical Research Future Fund (MRFF). DJE has had research grants from Bayer, Apnimed, Takeda, Invicta Medical, Eli Lilly and Withings. DJE currently serves as a scientific advisor/consultant for Apnimed, Invicta Medical, SleepRes, Takeda and Mosanna. ACR has received research funding from the Lifetime Support Authority, Sleep Health Foundation, Flinders Foundation, Compumedics, and Sydney Trains, and speaker and consultancy fees from Teva Pharmaceuticals, Sealy Australia, and the Sleep Health Foundation for work unrelated to this study. HS reports consultancy and/or research support from Re-Time Pty Ltd, Compumedics Ltd, the American Academy of Sleep Medicine Foundation, and Flinders University. JLP JLP has received lecture fees or conference travel grants from ResMed, Philips, Agiradom and Bioprojet, and has received unrestricted research funding from ResMed, Bioprojet, Fondation de la Recherche Medicale (Foundation for Medical Research), Direction de la Recherche Clinique du CHU de Grenoble (Research Branch Clinic CHU de Grenoble), and fond de dotation “Agir pour les Maladies Chroniques” (endowment fund “Acting for Chronic Diseases”). AV has received competitive research funding and equipment from ResMed and Philips Respironics for research unrelated to and outside the submitted work. PC reports grants from NHMRC, Medical Research Future Fund, Flinders Foundation, Invicta Medical, Garnett Passe and Rodney Williams Memorial Foundation, Defence Science and Technology Group. None of the other authors have any potential conflicts to declare.
